Search research articles
Contact Us
Filters
Showing results (31-40 of 191) with videos related to
Page
of 20
Sort By:
Cancer Immunology Research
|
February 14, 2018
Report on the NCI Microbial-Based Cancer Therapy Conference
Colleen S Curran, Avraham Rasooly, Min He, et al.
Journal for Immunotherapy of Cancer
|
February 24, 2015
Apical ballooning and cardiomyopathy in a melanoma patient treated with ipilimumab: a case of takotsubo-like syndrome
Benjamin P Geisler, Roy A Raad, Diana Esaian, et al.
International Journal of Molecular Sciences
|
February 13, 2026
CladeOScope-GSA: Revealing Evolutionary Associations Across Gene Sets
Maya Braun, Idit Bloch, Dana Sherill-Rofe, et al.
Cancer Cell
|
June 11, 2021
Developing and validating model systems for immuno-oncology
Claire E McCarthy, Nastaran Zahir, Mariam Eljanne, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 17, 2019
Report on the 2018 Cancer, Autoimmunity, and Immunology Conference
Colleen S Curran, Connie L Sommers, Howard A Young, et al.
Cancer Medicine
|
May 22, 2020
Incidence and survival of rare cancers in the US and Europe
Laura Botta, Gemma Gatta, Annalisa Trama, et al.
Bioinformatics (Oxford, England)
|
May 1, 2020
Optimization of co-evolution analysis through phylogenetic profiling reveals pathway-specific signals
Idit Bloch, Dana Sherill-Rofe, Doron Stupp, et al.
Clinical Trials (London, England)
|
March 18, 2025
Design considerations for randomized comparisons of neoadjuvant-adjuvant versus adjuvant-only cancer immunotherapy when tumor measurement schedules do not align (SWOG S1801)
Megan Othus, Elad Sharon, Michael C Wu, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
June 6, 2022
COVID-19 and Cancer: Special Considerations for Patients Receiving Immunotherapy and Immunosuppressive Cancer Therapies
Jason D Goldman, Michael A Gonzalez, Maria Madeleine Rüthrich, et al.
Journal of the National Cancer Institute
|
November 20, 2024
First cycle toxicity and survival in patients with rare cancers treated with checkpoint inhibitors
Megan Othus, Sandip P Patel, Young Kwang Chae, et al.
Page
of 20
Search research articles
Search
Showing results (31-40 of 191) with videos related to
Sort By:
Page
of 20
Cancer Immunology Research
|
February 14, 2018
Report on the NCI Microbial-Based Cancer Therapy Conference
Colleen S Curran, Avraham Rasooly, Min He, et al.
Journal for Immunotherapy of Cancer
|
February 24, 2015
Apical ballooning and cardiomyopathy in a melanoma patient treated with ipilimumab: a case of takotsubo-like syndrome
Benjamin P Geisler, Roy A Raad, Diana Esaian, et al.
International Journal of Molecular Sciences
|
February 13, 2026
CladeOScope-GSA: Revealing Evolutionary Associations Across Gene Sets
Maya Braun, Idit Bloch, Dana Sherill-Rofe, et al.
Cancer Cell
|
June 11, 2021
Developing and validating model systems for immuno-oncology
Claire E McCarthy, Nastaran Zahir, Mariam Eljanne, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 17, 2019
Report on the 2018 Cancer, Autoimmunity, and Immunology Conference
Colleen S Curran, Connie L Sommers, Howard A Young, et al.
Cancer Medicine
|
May 22, 2020
Incidence and survival of rare cancers in the US and Europe
Laura Botta, Gemma Gatta, Annalisa Trama, et al.
Bioinformatics (Oxford, England)
|
May 1, 2020
Optimization of co-evolution analysis through phylogenetic profiling reveals pathway-specific signals
Idit Bloch, Dana Sherill-Rofe, Doron Stupp, et al.
Clinical Trials (London, England)
|
March 18, 2025
Design considerations for randomized comparisons of neoadjuvant-adjuvant versus adjuvant-only cancer immunotherapy when tumor measurement schedules do not align (SWOG S1801)
Megan Othus, Elad Sharon, Michael C Wu, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
June 6, 2022
COVID-19 and Cancer: Special Considerations for Patients Receiving Immunotherapy and Immunosuppressive Cancer Therapies
Jason D Goldman, Michael A Gonzalez, Maria Madeleine Rüthrich, et al.
Journal of the National Cancer Institute
|
November 20, 2024
First cycle toxicity and survival in patients with rare cancers treated with checkpoint inhibitors
Megan Othus, Sandip P Patel, Young Kwang Chae, et al.
Page
of 20